DEAProposed Rule
Schedules of Controlled Substances: Placement of 3-methoxyphencyclidine (1-[1-(3-methoxyphenyl)cyclohexyl]piperidine) in Schedule I
HealthcareOther
Ad Space (leaderboard)
Summary
The DEA is proposing to officially ban a synthetic drug called 3-methoxyphencyclidine (a chemical similar to PCP) by placing it in Schedule I, the most restrictive category for illegal drugs. This action aims to prevent the drug from being manufactured, distributed, or possessed in the United States.
Key Points
- 1The DEA wants to make 3-methoxyphencyclidine illegal nationwide by classifying it as a Schedule I controlled substance, meaning it has no accepted medical use and a high potential for abuse
- 2This is a proposed rule, not final yet—the public has until July 11, 2025 to submit comments about whether this ban is a good idea
- 3If approved, manufacturing, selling, or possessing this drug would become a federal crime with serious penalties
- 4This targets a designer drug that mimics the effects of PCP and has emerged as a street drug threat in recent years
- 5The regulation primarily affects drug manufacturers, dealers, and users, as well as law enforcement agencies responsible for enforcement
Key Dates
Published
June 10, 2025
This summary is for informational purposes only. It may not capture all nuances of the regulation. Always refer to the official text for authoritative information.
The Digest Network
AI Comment Drafter
Describe your concern and we'll help you draft a substantive comment.
AI-generated draft. Always review and edit before submitting. Replace all [bracketed placeholders] with your specific details. Your comment should reflect your genuine views and experience.
Ad Space (rectangle)